Shafer Michael D's Form 4 filing
Thermo Fisher Scientific Inc. (TMO) · filed Mar 4, 2025
- Accession no.
- 0001127602-25-007937
- Filed
- Mar 4, 2025
- Trade date
- Feb 28-Mar 3, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $945.0K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Shafer Michael DCIK 0002020619 | Officer (Executive Vice President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 28, 2025 | Common Stock | FTax withholdingDisposed | −244.59 | $528.96 | −$129,378.33 | 21,804.88 | Direct | |
| Feb 28, 2025 | Common Stock | FTax withholdingDisposed | −109.77 | $528.96 | −$58,063.94 | 21,695.11 | Direct | |
| Feb 28, 2025 | Common Stock | FTax withholdingDisposed | −636.08 | $528.96 | −$336,460.88 | 21,059.02 | Direct | |
| Mar 3, 2025 | Common Stock | SSaleDisposed | −1,780 | $530.92 | −$945,037.6 | 19,279.02 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.